BCAX news

Latest 2 stories · newest Jul 28, 2026

BCAX
Bicara Appoints Bender, Oliger to Board

Bicara Therapeutics announced the appointment of Jeremy Bender and Christy Oliger to its board. The company also confirmed the retirement of founding director Kiran Mazumdar-Shaw.

Leadership Jul 28, 2026 sentiment 0.00 SEC filing ↗
BCAX
Ficerafusp alfa shows 31% three-year OS in HPV-negative HNSCC trial

Bicara's ficerafusp alfa plus pembrolizumab demonstrated approximately doubled overall survival compared to standard of care in first-line recurrent/metastatic HPV-negative head and neck cancer at three-year follow-up. The company is advancing the 1500mg weekly dose in its Phase 3 FORTIFI-HN01 pivot…

Regulatory May 21, 2026 sentiment +0.85 SEC filing ↗
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same BCAX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/BCAX/newsSTART FREE